Correlation Between GlaxoSmithKline PLC and Us Strategic
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Us Strategic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Us Strategic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Us Strategic Equity, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Us Strategic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Us Strategic. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Us Strategic.
Diversification Opportunities for GlaxoSmithKline PLC and Us Strategic
-0.9 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and RSECX is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Us Strategic Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Us Strategic Equity and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Us Strategic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Us Strategic Equity has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Us Strategic go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Us Strategic
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Us Strategic. In addition to that, GlaxoSmithKline PLC is 1.63 times more volatile than Us Strategic Equity. It trades about -0.23 of its total potential returns per unit of risk. Us Strategic Equity is currently generating about 0.38 per unit of volatility. If you would invest 1,736 in Us Strategic Equity on September 1, 2024 and sell it today you would earn a total of 110.00 from holding Us Strategic Equity or generate 6.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Us Strategic Equity
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Us Strategic Equity |
GlaxoSmithKline PLC and Us Strategic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Us Strategic
The main advantage of trading using opposite GlaxoSmithKline PLC and Us Strategic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Us Strategic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Us Strategic will offset losses from the drop in Us Strategic's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Us Strategic vs. International Developed Markets | Us Strategic vs. Global Real Estate | Us Strategic vs. Global Real Estate | Us Strategic vs. Growth Strategy Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |